These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18471905)

  • 1. Barriers in the brain: a renaissance?
    Saunders NR; Ek CJ; Habgood MD; Dziegielewska KM
    Trends Neurosci; 2008 Jun; 31(6):279-86. PubMed ID: 18471905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The blood-brain barrier and drug delivery in the central nervous system].
    Loch-Neckel G; Koepp J
    Rev Neurol; 2010 Aug; 51(3):165-74. PubMed ID: 20645267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and function of the blood-brain barrier.
    Abbott NJ; Patabendige AA; Dolman DE; Yusof SR; Begley DJ
    Neurobiol Dis; 2010 Jan; 37(1):13-25. PubMed ID: 19664713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug targeting to the brain.
    de Boer AG; Gaillard PJ
    Annu Rev Pharmacol Toxicol; 2007; 47():323-55. PubMed ID: 16961459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug delivery to the central nervous system: a review.
    Misra A; Ganesh S; Shahiwala A; Shah SP
    J Pharm Pharm Sci; 2003; 6(2):252-73. PubMed ID: 12935438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macromolecular drug transport into the brain using targeted therapy.
    Lichota J; Skjørringe T; Thomsen LB; Moos T
    J Neurochem; 2010 Apr; 113(1):1-13. PubMed ID: 20015155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of the blood-brain barrier: animal models and methods.
    Hawkins BT; Egleton RD
    Curr Top Dev Biol; 2008; 80():277-309. PubMed ID: 17950377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barrier mechanisms in the brain, I. Adult brain.
    Saunders NR; Habgood MD; Dziegielewska KM
    Clin Exp Pharmacol Physiol; 1999 Jan; 26(1):11-9. PubMed ID: 10027064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." The blood-brain barrier: a physical and conceptual challenge.
    Hachinski V; Lee TY
    Alzheimers Dement; 2009 Sep; 5(5):435-6. PubMed ID: 19751924
    [No Abstract]   [Full Text] [Related]  

  • 10. Strategies to advance translational research into brain barriers.
    Neuwelt E; Abbott NJ; Abrey L; Banks WA; Blakley B; Davis T; Engelhardt B; Grammas P; Nedergaard M; Nutt J; Pardridge W; Rosenberg GA; Smith Q; Drewes LR
    Lancet Neurol; 2008 Jan; 7(1):84-96. PubMed ID: 18093565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro models of the blood-brain barrier.
    Wilhelm I; Fazakas C; Krizbai IA
    Acta Neurobiol Exp (Wars); 2011; 71(1):113-28. PubMed ID: 21499332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiology of blood-brain interfaces in relation to brain disposition of small compounds and macromolecules.
    Strazielle N; Ghersi-Egea JF
    Mol Pharm; 2013 May; 10(5):1473-91. PubMed ID: 23298398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." Alzheimer's disease drugs: more than one barrier to breach.
    Roher AE; Kokjohn TA
    Alzheimers Dement; 2009 Sep; 5(5):437-8. PubMed ID: 19751925
    [No Abstract]   [Full Text] [Related]  

  • 14. Carrier-mediated delivery of metabotrophic glutamate receptor ligands to the central nervous system: structural tolerance and potential of the L-system amino acid transporter at the blood-brain barrier.
    Reichel A; Begley DJ; Abbott NJ
    J Cereb Blood Flow Metab; 2000 Jan; 20(1):168-74. PubMed ID: 10616805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoneurotoxicity to nanoneuroprotection using biological and computational approaches.
    Iqbal A; Ahmad I; Khalid MH; Nawaz MS; Gan SH; Kamal MA
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2013; 31(3):256-84. PubMed ID: 24024521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: a review.
    Bicker J; Alves G; Fortuna A; Falcão A
    Eur J Pharm Biopharm; 2014 Aug; 87(3):409-32. PubMed ID: 24686194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of the blood-brain barrier in Alzheimer's disease].
    Gosselet F; Candela P; Cecchelli R; Fenart L
    Med Sci (Paris); 2011 Nov; 27(11):987-92. PubMed ID: 22130026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of drug transporters at the blood-brain barrier.
    Fricker G; Miller DS
    Pharmacology; 2004 Apr; 70(4):169-76. PubMed ID: 15001817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain iron homeostasis.
    Moos T
    Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of peptide and protein drugs over the blood-brain barrier.
    Brasnjevic I; Steinbusch HW; Schmitz C; Martinez-Martinez P;
    Prog Neurobiol; 2009 Apr; 87(4):212-51. PubMed ID: 19395337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.